loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 21911 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 RUFINAMIDE (3)

filter

01 EISAI INC (3)

filter

01 TABLET;ORAL (3)

filter

01 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 200MG (1)

03 400MG (1)

filter

01 USA (3)

URL Supplier Web Content
TABLET;ORAL
100MG **Federal Regist...
BANZEL
USA
21911
2008-11-14
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
200MG
BANZEL
USA
21911
2008-11-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET;ORAL
400MG
BANZEL
USA
21911
2008-11-14
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 21911

Looking for CTD TGA MCC DOSSIER APPLICATION 21911 3

19

Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUFINAMIDE, with a corresponding application number 21911 and regulatory information .

proudly manufactured in the

approval since 2008-11-14

Eisai Inc's BANZEL TABLET;ORAL, medication with 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of RUFINAMIDE.

18

Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUFINAMIDE, with a corresponding application number 21911 and regulatory information .

proudly manufactured in the

approval since 2008-11-14

Eisai Inc's BANZEL TABLET;ORAL, medication with 200MG of RUFINAMIDE.

17

Eisai Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is RUFINAMIDE, with a corresponding application number 21911 and regulatory information .

proudly manufactured in the

approval since 2008-11-14

Eisai Inc's BANZEL TABLET;ORAL, medication with 400MG of RUFINAMIDE.

Post Enquiry
POST ENQUIRY